This page is maintained and edited by Willian Smith (Editor at World Wide News Flash since July, 2009).
You can contribute to this page by sending an email to [email protected] or by using our contact form below.

Genzyme

July 24, 2010 Stocks Rise After Euro Bank Tests, Earnings Send by The Associated Press A report that Sanofi-Aventis is looking to buy biotechnology company Genzyme is also boosting markets. Mergers and acquisitions activity is also a sign [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

August 30, 2010 Genzyme Rejects Sanofi-Aventis Offer : Jumping Anaconda Send by Jumping Anaconda Biotechnology company Genzyme rejects Sanofi-Aventis SA's $18.5 billion buyout offer, saying the bid undervalues the company.On Sunday, Sanofi-Aventis offered $69-per-share for Genzyme, which has been struggling in the aftermath of [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

September 27, 2010 LabCorp To Acquire Genzyme Genetics Send by Zacks Investment Research Leading diagnostic company Laboratory Corporation of America Holdings (LH) has decided to acquire Genzyme Genetics, a unit of Genzyme Corporation (GENZ) for. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

October 05, 2010 Sanofi-aventis Launches $18.5bn Hostile Takeover Offer For Genzyme Posted by Willian Smith The $69 per share offer is unchanged from the friendly proposal sanofi-aventis made privately to Genzyme's board of directors in July, which was promptly rejected publicly in August. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

September 27, 2010 Sanofi Says Holds Offer For Genzyme At $69/share Send by news.yahoo.com Sanofi-Aventis has not changed its offer of $69 per share for drugmaker Genzyme, a Sanofi spokesman said Monday, declining to comment on a report that the drugmaker had lined up more financing for its bid. [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

October 04, 2010 NewsDaily: Sanofi Says Holds Offer For Genzyme At $69/share Posted by Willian Smith Sanofi-Aventis has not changed its offer of $69 per share for drugmaker Genzyme, a Sanofi spokesman said Monday, declining to comment on a report that the drugmaker had lined up more financing for its bid. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

August 30, 2010 Analysts: Sanofi Won't Go Hostile For Genzyme - FiercePharma Send by Tracy Staton Back when the news of Sanofi-Aventis' (NYSE: SNY) interest in Genzyme (NASDAQ: GENZ) broke, analysts and other industry observers were speculating about the prospect of a hostile bid. Word was that [...] Read more [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 23, 2010 Scripintelligence - Genzyme Shareholders Urged To Vote For Icahn ... Posted by Willian Smith Carl Icahn has again criticised Genzyme in the ongoing battle for control over the beleaguered biotech, saying that the firm's. [...] Rating: No stars. Rate up / Rate down Report to moderator

August 30, 2010 Sanofi Reveals Its Bid For Genzyme ? New York Times | Nowcosm Send by Edna Reuters IndiaSanofi Reveals Its Bid for GenzymeNew York TimesSanofi-Aventis, the French drug maker, publicly disclosed its $18.5 billion bid for the Americ [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

August 30, 2010 WBSI, WebSafety, Inc. And GENZ, Genzyme Corp. ? CRWESelect.com ... Posted by Willian Smith WebSafety, Inc. (WBSI.OB) is the leading provider of mobile and computer software solutions that help to prevent incidences of distracted driving as. [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

August 30, 2010 Sanofi-Aventis Makes $18.5 Billion Offer For Genzyme (Reuters) | EnUws Posted by Willian Smith Reuters - France's Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme Corp in a [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

October 04, 2010 Sanofi-Aventis Launches Genzyme Takeover Battle (AP) Posted by Willian Smith AP - Sanofi-Aventis launched a hostile takeover battle Monday for Genzyme Corp. aimed at capturing the U.S. biotech company's promising drugs for high cholesterol and lucrative treatments for rare genetic disorders. [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

August 30, 2010 Genzyme Rejects Sanofi Bid Posted by Willian Smith US biotechnology company Genzyme Corp. has rejected an $18.5-billion US takeover bid from Paris-based rival Sanofi-Aventis SA, saying it's not enough. CBC | Health News Related News:Genzyme Spurns Sanofi Bid Genzyme confirmed that its [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

October 04, 2010 Biotech Stocks To Keep An Eye-On: Seattle Genetics, Inc., Genzyme ... Send by Jane Wells Genzyme Corporation (NASDAQ:GENZ) slid 0.56% to $71.20 on over 2.75 million shares. Sanofi-Aventis has not changed its offer of $69 per share for drugmaker Genzyme, a Sanofi spokesman said Monday, declining to comment on a report it may [...] Rating: No stars. Rate up / Rate down Report to moderator

August 30, 2010 Sanofi-Aventis Goes Public With $18.5 Billion Genzyme Bid, Hints ... Posted by Willian Smith The bid was followed by, "several unsuccessful attempts" to discuss the bid with Genzyme management. According to the press release, the "transaction would help Genzyme achieve its vision of making a positive impact on the lives of [...] Rating: 3 out of 5 stars Rate up / Rate down Report to moderator

July 24, 2010 Genzyme Corp., Biogen Idec, McDonald's: US Equity Movers Send by BusinessWeek Genzyme Corp. (GENZ US) jumped 16 percent to $62.91 for the biggest gain in the S&P 500. The biotechnology company received a takeover offer from French [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

---

Submit article

Name:
E-Mail:
Source:
Article:
Please complete all the fields in order to take your article in consideration.